SG Americas Securities
RIGL icon

SG Americas Securities’s Rigel Pharmaceuticals RIGL Stock Holding History

SG Americas Securities’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,690
Closed -$2K – 3576
2018
Q4 		$2K Hold
3,690
– – ﹤0.01% 3008
2018
Q3 		$5K Hold
3,690
– – ﹤0.01% 3076
2018
Q2 		$10K Buy
+3,690
New +$131K ﹤0.01% 3271

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SG Americas Securities's RIGL Position: Q2 2026 in Review

SG Americas Securities reduced its Rigel Pharmaceuticals (RIGL) stake by 76% in Q2 2026, selling an estimated $320K and leaving 3,316 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #2991.

SG Americas Securities first reported a position in RIGL in Q3 2013 and has held it in 36 quarters since. The position peaked at $1.53M in Q4 2020. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • SG Americas Securities held 3,316 shares of Rigel Pharmaceuticals worth $130K as of Q2 2026.
  • SG Americas Securities sold 10,371 Rigel Pharmaceuticals shares in Q2 2026, an estimated $320K.
  • Rigel Pharmaceuticals made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2991 holding.
  • SG Americas Securities first reported a position in Rigel Pharmaceuticals in Q3 2013 and has held it in 36 quarters since.
  • SG Americas Securities's Rigel Pharmaceuticals position peaked at $1.53M in Q4 2020.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.